Viewing Study NCT03071133


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-03-02 @ 4:08 AM
Study NCT ID: NCT03071133
Status: COMPLETED
Last Update Posted: 2022-02-23
First Post: 2017-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module